On November 7, 2016, Spotlight Innovation Inc. has entered into an Exclusive License Agreement with Florida State University Research Foundation to commercialize certain compounds that may have therapeutic potential for treating viral infections, including Zika virus infection. The Company will file a copy of the License Agreement with its 10-Q for the quarter ended September 30, 2016 in redacted form subject to an application for confidential treatment the Company is making with the Securities and Exchange Commission.